Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect
Yıl: 2019 Cilt: 34 Sayı: 1 Sayfa Aralığı: 100 - 104 Metin Dili: İngilizce DOI: 10.5606/ArchRheumatol.2019.6882 İndeks Tarihi: 27-01-2020
Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect
Öz: The use of anti-tumor necrosis factor (anti-TNF) therapies for treatment of rheumatic diseases is increasing every day and the results are positive.Case reports about skin reactions developing after use of these medications - newly developing psoriasis, increase/flare-up of existing psoriasis - arefound in the literature at rates that cannot be ignored. Psoriasis developing after the use of these agents for treatment is a paradoxical side effect,with no clear understanding of the cause though several hypotheses exist. In this article, we present five cases with this paradoxical side effectdeveloping after anti-TNF treatment accompanied by the literature with the aim of aiding in finding an approach to these cases.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. López-Robles A, Queiro R, Alperi M, Alonso S, Riestra JL, Ballina J. Psoriasis and psoriasiform lesions induced by TNFa antagonists: the experience of a tertiary care hospital from northern Spain. Rheumatol Int 2012;32:3779-83.
- 2. Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010;40:233-40.
- 3. Gannes G, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, et al. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007;143:223-31.
- 4. Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci U S A 2005;102:3372-7.
- 5. González-López MA, Martínez-Taboada VM, González-Vela MC, Fernández-Llaca H, Val-Bernal JF. New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra. Br J Dermatol 2008;158:1146-8.
- 6. Dass S, Vital EM, Emery P. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 2007;56:2715-8.
- 7. Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 2008;59:996-1001.
- 8. Harrison MJ, Dixon WG, Watson KD, King Y, Groves R, Hyrich KL, et al. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving antitumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2009;68:209-15.
| APA | KUTLUK Ö, ÜNAL ENGİNAR A, BALCI N, BÜTÜN B, KAÇAR C (2019). Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. , 100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| Chicago | KUTLUK Öznur,ÜNAL ENGİNAR Ayşe,BALCI Nilüfer,BÜTÜN Bülent,KAÇAR Cahit Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. (2019): 100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| MLA | KUTLUK Öznur,ÜNAL ENGİNAR Ayşe,BALCI Nilüfer,BÜTÜN Bülent,KAÇAR Cahit Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. , 2019, ss.100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| AMA | KUTLUK Ö,ÜNAL ENGİNAR A,BALCI N,BÜTÜN B,KAÇAR C Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. . 2019; 100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| Vancouver | KUTLUK Ö,ÜNAL ENGİNAR A,BALCI N,BÜTÜN B,KAÇAR C Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. . 2019; 100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| IEEE | KUTLUK Ö,ÜNAL ENGİNAR A,BALCI N,BÜTÜN B,KAÇAR C "Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect." , ss.100 - 104, 2019. 10.5606/ArchRheumatol.2019.6882 |
| ISNAD | KUTLUK, Öznur vd. "Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect". (2019), 100-104. https://doi.org/10.5606/ArchRheumatol.2019.6882 |
| APA | KUTLUK Ö, ÜNAL ENGİNAR A, BALCI N, BÜTÜN B, KAÇAR C (2019). Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. Archives of Rheumatology, 34(1), 100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| Chicago | KUTLUK Öznur,ÜNAL ENGİNAR Ayşe,BALCI Nilüfer,BÜTÜN Bülent,KAÇAR Cahit Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. Archives of Rheumatology 34, no.1 (2019): 100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| MLA | KUTLUK Öznur,ÜNAL ENGİNAR Ayşe,BALCI Nilüfer,BÜTÜN Bülent,KAÇAR Cahit Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. Archives of Rheumatology, vol.34, no.1, 2019, ss.100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| AMA | KUTLUK Ö,ÜNAL ENGİNAR A,BALCI N,BÜTÜN B,KAÇAR C Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. Archives of Rheumatology. 2019; 34(1): 100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| Vancouver | KUTLUK Ö,ÜNAL ENGİNAR A,BALCI N,BÜTÜN B,KAÇAR C Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect. Archives of Rheumatology. 2019; 34(1): 100 - 104. 10.5606/ArchRheumatol.2019.6882 |
| IEEE | KUTLUK Ö,ÜNAL ENGİNAR A,BALCI N,BÜTÜN B,KAÇAR C "Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect." Archives of Rheumatology, 34, ss.100 - 104, 2019. 10.5606/ArchRheumatol.2019.6882 |
| ISNAD | KUTLUK, Öznur vd. "Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect". Archives of Rheumatology 34/1 (2019), 100-104. https://doi.org/10.5606/ArchRheumatol.2019.6882 |
